Supplement study for pancreatic cancer patients withdrawn before it began
NCT ID NCT05360745
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to see if a food supplement called ARACOMPLEX® could help maintain quality of life in patients with advanced pancreatic cancer receiving chemotherapy. The supplement contains maca extract, vitamins, and minerals. However, the trial was withdrawn before enrolling any participants, so no data were collected.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ARACOMPLEX® (a food supplement with maca extract, vitamins, and minerals)
- What this could lead to
- If it worked, this could point toward a simple nutritional supplement to help maintain quality of life during chemotherapy for advanced pancreatic cancer.
- What could go wrong
- The trial was withdrawn before enrolling any participants, so no results are available. Even if conducted, food supplements rarely have strong effects on cancer outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED PANCREATIC CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Tape to tame Post-Surgery face swelling?
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Smartwatch could spot nerve damage before it starts
- Can healing at home beat hospital care for bedsores?
- Can virtual reality make knee pain therapy more engaging?
- Can sound waves outperform needles for Jumper's knee?